Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination. - Orrù V; Serra V; Marongiu M; Lai S; Lodde V; Zoledziewska M; Steri M; Loizedda A; Lobina M; Piras MG; Virdis F; Delogu G; et al. (Frontiers in immunology, 2024)